Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterials - Deinove

Drug Profile

Research programme: antibacterials - Deinove

Alternative Names: Bacterial topoisomerase I inhibitors - Deinove; Enzyme inhibitors - Deinove; MCB 1033; MCB 116; MCB-4657; MCB-4658; MCTI programme - Deinove; Topoisomerase inhibitors - Deinove; Topoisomerase IV inhibitors - Deinove

Latest Information Update: 07 Feb 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Morphochem AG
  • Class Oxazolidinones; Small molecules
  • Mechanism of Action DNA topoisomerase inhibitors; Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Suspended Bacterial infections

Most Recent Events

  • 15 Dec 2006 Suspended - Preclinical for Bacterial infections in Switzerland (unspecified route)
  • 15 Dec 2006 Suspended - Preclinical for Bacterial infections in USA (unspecified route)
  • 17 Oct 2006 Data presented at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2006) have been added to the Bacterial Infections pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top